RxREVU hits the $1 million funding milestone


Prescription optimization solution provider RxREVU announced additional funding which brings the total amount raised to $1 million. Investors include Nat Turner and Zach Weinberg, co-founders of Flatiron Health (a Google Ventures led recipient of $130 million in Series B funding), Vivek Garipalli, co-founder of CarePoint Health, Arnold Schaeffer, founder of Spring Valley Capital and an original senior executive at VeriSign, and Galvanize Ventures.

“Reaching this milestone shows confidence in our ability to continue delivering prescription drug cost and efficacy information to engage consumers, identify medication cost saving opportunities and improve clinical outcomes,” said Carm Huntress, CEO of RxREVU. “While we had initially planned on raising much less, the demand for our prescription optimization solutions has been extremely high. We now have the opportunity to expand quickly and are well-capitalized to meet customer demands.”

RxREVU has recently announced partnerships with several leading companies delivering solutions for patient engagement to millions of combined users, including Yingo Yango, Medullan and most recently Medical Home Exchange.